Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Risk factors for ischemic stroke in patients with Philadelphia chromosome (Ph)-negative myeloproliferative neoplasms.

Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia - 1 Jul 2024

Wen Shirong, Zhang Wenxiao, Fei Yiping, Guan Ke, Zhao Hui, Song Peng, Ye Xiangmei, Pan Yujun

Abstract excerpt

BACKGROUND: Philadelphia chromosome-negative myeloproliferative neoplasms (Ph-negative MPNs) are linked with various complications, notably ischemic stroke. The study aims to identify risk factors for ischemic stroke in Ph-negative MPNs patients. METHODS: Patients were categorized into two groups based on whether they had experienced ischemic stroke. Subsequently, an analysis of demographics, biochemical makers,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged, 80 and over
Share to Calreticulin

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hypertension

Share to Ischemic Stroke

Share to Janus Kinase 2

Share to Myeloproliferative Disorders

Share to Philadelphia Chromosome

Share to Smoking

Source

Identifiers

PMID: 38815302
DOI: 10.1016/j.jocn.2024.05.025

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Risk factors for ischemic stroke in patients with Philadelphia chromosome (Ph)-negative myeloproliferative neoplasms.PMID 38815302Read ↗

Cerebrovascular risk factors are the predictive factor for ischemic cerebrovascular diseases in patients with Philadelphia chromosome (Ph)–negative myeloproliferative neoplasms: a case control studySemantic proximity Read ↗

Prevalence and Clinical Characteristics of Patients with Ischemic Stroke with <i>JAK2</i> V617F Mutation and Normal Blood CountsSemantic proximity Read ↗

Clinical Manifestations and Risk Factors for Complications of Philadelphia Chromosome-Negative Myeloproliferative Neoplasms.Semantic proximity Read ↗

Essential Thrombocythemia and Ischemic Stroke: A Case Series of Five JAK2-Positive PatientsSemantic proximity Read ↗

Essential Thrombocythemia and Ischemic Stroke: A Case Series of Five JAK2-Positive Patients.Semantic proximity Read ↗

A higher JAK2V617F allele burden may be a risk factor for hemorrhagic events in younger patients with polycythemia vera.Semantic proximity Read ↗

Thromboinflammation in ischemic cerebrovascular patients with the JAK2V617F mutation.Semantic proximity Read ↗

JAK2 V617F Mutation and Large Cerebral Artery Disease in Patients with Myeloproliferative Neoplasms.Semantic proximity Read ↗

Enhanced Risk for Specific Somatic Myeloproliferative Neoplastic Mutations in Patients with Stroke.Semantic proximity Read ↗

Splenic Infarction in Patients with Philadelphia-negative Myeloproliferative Neoplasms.Semantic proximity Read ↗

Implications of Janus Kinase 2 Mutation in Embolic Stroke of Unknown Source.Semantic proximity Read ↗

Clinical characteristics and brain MRI findings in myeloproliferative neoplasms.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.